Streetbeat News

ROVR

Rover Group Inc

https://www.rover.com/

CEO

Aaron Easterly

Employees

372

Industry

Offices of Lawyers

Rover.com is an American company which operates an online marketplace for people to buy and sell pet care services including pet sitting, dog boarding, and dog walking. Rover.com was founded in 2011 in Seattle, Washington and is formally incorporated under the name "A Place for Rover, Inc.

Open

10.99

Mkt cap

Volume

1.3M

High

11.00

P/E Ratio

183.25

52-wk high

11.10

Low

10.99

Div yield

N/A

52-wk low

3.75

Rover Group has entered into a definitive agreement to be acquired by Blackstone in a transaction valued at $2.3 billion. Stockholders are set to receive $11 per share in cash.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:03 pm

Five consumer discretionary stocks are considered overbought based on their RSI values, which may signal a potential short-term decline. Newegg Commerce (NEGG) authorized a share repurchase program, Superior Group of Companies (SGC) reported strong Q3 earnings, TAL Education Group (TAL) exceeded quarterly expectations, Texas Roadhouse (TXRH) had weaker Q3 earnings but solid sales growth, and Rover Group (ROVR) posted strong Q3 results and raised FY23 guidance.

Portfolio Pulse from Lisa Levin

November 29, 2023 | 1:16 pm

Rover Group (NASDAQ:ROVR) has been rated by 4 analysts in the last quarter, with 1 somewhat bullish and 3 indifferent ratings. The average price target is now $7.69, up 16.16% from the previous target of $6.62, but still implies a downside from the current price of $8.4. Analysts' ratings are a mix of predictions and beliefs about a company's performance and are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 6:00 pm

JMP Securities analyst Andrew Boone has maintained a Market Outperform rating on Rover Group (NASDAQ:ROVR) and increased the price target from $8 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 1:50 pm

Morgan Stanley analyst Lauren Schenk has maintained an Equal-Weight rating on Rover Group (NASDAQ:ROVR) and raised the price target from $6.5 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:34 pm

JP Morgan analyst Cory Carpenter maintains a Neutral rating on Rover Group (NASDAQ:ROVR) and raises the price target from $6 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 8:04 pm

Rover reported better-than-expected Q3 financial results and issued Q4 revenue guidance above estimates. The company also raised FY23 revenue guidance above estimates and announced an extension of its share repurchase program. This has led to a rise in Rover's share price.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:18 pm

The article lists the stocks that gained and lost the most in Tuesday's mid-day session. Among the gainers were PaxMedica, Senti Biosciences, Tharimmune, TransMedics Group, and Singular Genomics Systems. Among the losers were Ventyx Biosciences, Alto Ingredients, Worldwide Webb Acquisition Corp, Oportun Financial Corporation, and Royalty Management Holding Corporation.

Portfolio Pulse from Lisa Levin

November 07, 2023 | 6:10 pm

Several consumer discretionary stocks experienced significant movement during Tuesday's intraday session. Notable gainers included Rover Group, Vacasa, Esports Entertainment, Bowlero, Planet Fitness, and Solo Brands, with increases ranging from 11.89% to 20.2%. On the other hand, ThredUp, Kaixin Auto Hldgs, Color Star Tech, EpicQuest Education Group, ECARX Holdings, and Melco Resorts and Enter saw decreases ranging from 10.72% to 34.6%. Most of these movements were associated with recent Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 5:31 pm

Several US stocks recorded gains on Tuesday, with notable increases for TransMedics Group, Olaplex Holdings, Datadog, Augmedix, Rover Group, Matterport, MacroGenics, Verve Therapeutics, GDEV, Triumph Group, Alteryx, Thoughtworks Holding, TaskUs, Myriad Genetics, Planet Fitness, EverQuote, Oscar Health, Hims & Hers Health, Surgery Partners, Vimeo, MongoDB, PRA Group, BioMarin Pharmaceutical, Snowflake, DigitalOcean Holdings, DocGo, Appian Corporation, Teradata Corporation, and Tripadvisor. These gains were largely driven by better-than-expected Q3 results and strong FY23 revenue guidance.

Portfolio Pulse from Lisa Levin

November 07, 2023 | 3:54 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.